JPS5659707A - Lasting antibiotic pharmaceutical and its preparation - Google Patents

Lasting antibiotic pharmaceutical and its preparation

Info

Publication number
JPS5659707A
JPS5659707A JP13564479A JP13564479A JPS5659707A JP S5659707 A JPS5659707 A JP S5659707A JP 13564479 A JP13564479 A JP 13564479A JP 13564479 A JP13564479 A JP 13564479A JP S5659707 A JPS5659707 A JP S5659707A
Authority
JP
Japan
Prior art keywords
amphoteric
lactam antibiotic
antacid agent
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13564479A
Other languages
Japanese (ja)
Inventor
Masaki Hasegawa
Mitsuru Fukushima
Renji Aikawa
Mutsuhiro Mori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP13564479A priority Critical patent/JPS5659707A/en
Publication of JPS5659707A publication Critical patent/JPS5659707A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: The titled lasting pharmaceutical, capable of retaining the effective blood concentration without the pH dependence and with a few frequency of administration, and prepared by coating the surface of a particle containing an amphoteric β-lactam antibiotic and an antacid agent as active components.
CONSTITUTION: A pharmaceutical prepared by coating the surface of a particle containing an amphoteric β-lactam antibiotic, e.g. cephalexin, cephaloglycin, cephradine or cefadroxil, and an antacid agent e.g. calcium or magnesium carbonate, preferably at a weight ratio between the amphoteric β-lactam antibiotic and the antacid agent of 100:5W100:200 with ethyl cellulose. The amphoteric β-lactam antibiotic and the antacid agent are preferably granulated by the wet method in the presence of a binder, and methyl cellulose, ethyl cellulose or hydroxypropyl methyl cellulose may be cited as the binder.
COPYRIGHT: (C)1981,JPO&Japio
JP13564479A 1979-10-19 1979-10-19 Lasting antibiotic pharmaceutical and its preparation Pending JPS5659707A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13564479A JPS5659707A (en) 1979-10-19 1979-10-19 Lasting antibiotic pharmaceutical and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13564479A JPS5659707A (en) 1979-10-19 1979-10-19 Lasting antibiotic pharmaceutical and its preparation

Publications (1)

Publication Number Publication Date
JPS5659707A true JPS5659707A (en) 1981-05-23

Family

ID=15156615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13564479A Pending JPS5659707A (en) 1979-10-19 1979-10-19 Lasting antibiotic pharmaceutical and its preparation

Country Status (1)

Country Link
JP (1) JPS5659707A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
JPS6323814A (en) * 1986-07-09 1988-02-01 メルク　シヤ−プ　エンド　ド−ム　リミテツド Slow-release medicinal composition of oral administration form
WO1993001800A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
CN112972416A (en) * 2021-03-30 2021-06-18 海南海力制药有限公司 Preparation method of cefradine capsule

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139713A (en) * 1976-05-13 1977-11-21 Shionogi & Co Ltd Sustained release cefalexin preparations
JPS5325005A (en) * 1976-08-19 1978-03-08 Marutai Doboku Kk Method of driving steellpipe pile

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139713A (en) * 1976-05-13 1977-11-21 Shionogi & Co Ltd Sustained release cefalexin preparations
JPS5325005A (en) * 1976-08-19 1978-03-08 Marutai Doboku Kk Method of driving steellpipe pile

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
JPS6323814A (en) * 1986-07-09 1988-02-01 メルク　シヤ−プ　エンド　ド−ム　リミテツド Slow-release medicinal composition of oral administration form
WO1993001800A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
US5484609A (en) * 1991-07-24 1996-01-16 Enzacor Properties Limited Therapeutic compositions and methods
CN112972416A (en) * 2021-03-30 2021-06-18 海南海力制药有限公司 Preparation method of cefradine capsule

Similar Documents

Publication Publication Date Title
AU8050791A (en) Compositions and methods for the controlled release of soluble active substances
AU6952687A (en) Process for the preparation of granules containing an active substance and to the use therefor as speckles for treating substrates
UA26303A1 (en) PHARMACEUTICAL COMPOSITION WITH IMHUSOSPRESSOR AND ACTIMICROBIAL ACTIVITY
JPS53113008A (en) Constant rate releasing preparation
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
IL90052A0 (en) Alpha-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters,their preparation and pharmaceutical compositions containing them
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
KR910014120A (en) Oral Pharmaceutical Formulations of Fimovevenan
EA199900205A1 (en) DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING BETA-LACTAM ANTIBIOTIC
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
CA2211325A1 (en) Extended release clonidine formulation
IE782422L (en) Dispersions of clavulanic acid particles
MY113718A (en) Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system, and process for the preparation of the formulation
HUT39568A (en) Insecticide and acaricide compositions containing 13beta-alkyl-milbemycin derivatives as active ingredients further process for preparing the active substances
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
JPS52139713A (en) Sustained release cefalexin preparations
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
NO962129L (en) New pharmaceutical composition for the preparation of a stable powder containing an active principle comprising a compound of acetylsalicylic acid and metoclopramide
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS52105220A (en) Composition for rectal administration comprising beta-lactam ring containing substance and method of making same
ES8502332A1 (en) Galenic forms of sulpiride for oral administration.
JPS5513252A (en) Preventive and remedy for swine dysentry
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
MY101266A (en) Pharmaceutical formulations